Estée Lauder Companies Valuation
Is EL * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of EL * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: EL * (MX$2500) is trading below our estimate of fair value (MX$2527.93)
Significantly Below Fair Value: EL * is trading below fair value, but not by a significant amount.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for EL *?
Other financial metrics that can be useful for relative valuation.
What is EL *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$52.59b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 3.9x |
Enterprise Value/EBITDA | 28.8x |
PEG Ratio | 2.1x |
Price to Earnings Ratio vs Peers
How does EL *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 29.2x | ||
500696 Hindustan Unilever | 51x | 8.6% | ₹5.2t |
KVUE Kenvue | 21.7x | 8.2% | US$36.0b |
HLN Haleon | 29.6x | 11.7% | UK£31.0b |
KIMBER A Kimberly-Clark de México S. A. B. de C. V | 14.7x | 6.8% | Mex$108.9b |
EL * Estée Lauder Companies | 71.2x | 33.1% | Mex$52.6b |
Price-To-Earnings vs Peers: EL * is expensive based on its Price-To-Earnings Ratio (71.2x) compared to the peer average (29.2x).
Price to Earnings Ratio vs Industry
How does EL *'s PE Ratio compare vs other companies in the Global Personal Products Industry?
Price-To-Earnings vs Industry: EL * is expensive based on its Price-To-Earnings Ratio (71.2x) compared to the Global Personal Products industry average (24.7x).
Price to Earnings Ratio vs Fair Ratio
What is EL *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 71.2x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate EL *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$2,500.00 | Mex$2,741.37 +9.7% | 11.4% | Mex$3,575.38 | Mex$2,230.35 | n/a | 27 |
Apr ’25 | Mex$2,524.00 | Mex$2,669.35 +5.8% | 11.5% | Mex$3,491.08 | Mex$2,177.77 | n/a | 27 |
Mar ’25 | n/a | Mex$2,734.77 0% | 11.3% | Mex$3,573.91 | Mex$2,229.44 | n/a | 28 |
Feb ’25 | Mex$2,212.90 | Mex$2,502.98 +13.1% | 16.9% | Mex$3,579.41 | Mex$1,979.00 | n/a | 29 |
Jan ’25 | Mex$2,459.53 | Mex$2,374.29 -3.5% | 19.7% | Mex$3,531.86 | Mex$1,698.01 | n/a | 29 |
Dec ’24 | Mex$2,265.00 | Mex$2,360.02 +4.2% | 21.2% | Mex$3,601.23 | Mex$1,731.36 | n/a | 29 |
Nov ’24 | Mex$1,860.00 | Mex$3,023.54 +62.6% | 20.6% | Mex$4,435.26 | Mex$1,781.23 | n/a | 27 |
Oct ’24 | Mex$2,440.00 | Mex$3,271.60 +34.1% | 13.5% | Mex$4,365.39 | Mex$2,559.63 | n/a | 28 |
Sep ’24 | Mex$2,756.26 | Mex$3,189.95 +15.7% | 14.0% | Mex$4,173.22 | Mex$2,446.95 | n/a | 28 |
Aug ’24 | Mex$2,963.25 | Mex$3,772.90 +27.3% | 10.7% | Mex$4,468.24 | Mex$3,035.03 | n/a | 28 |
Jul ’24 | Mex$3,375.00 | Mex$4,028.34 +19.4% | 10.0% | Mex$4,620.24 | Mex$3,080.16 | n/a | 29 |
Jun ’24 | Mex$3,274.18 | Mex$4,221.57 +28.9% | 8.7% | Mex$4,775.87 | Mex$3,183.91 | n/a | 30 |
May ’24 | Mex$4,411.98 | Mex$5,101.90 +15.6% | 7.8% | Mex$5,737.15 | Mex$3,765.01 | Mex$2,500.00 | 31 |
Apr ’24 | Mex$4,444.80 | Mex$5,161.41 +16.1% | 7.8% | Mex$5,789.63 | Mex$3,799.45 | Mex$2,524.00 | 31 |
Mar ’24 | Mex$4,487.36 | Mex$5,222.90 +16.4% | 8.5% | Mex$5,873.89 | Mex$3,854.74 | n/a | 31 |
Feb ’24 | Mex$5,179.13 | Mex$5,057.64 -2.3% | 10.1% | Mex$5,909.18 | Mex$3,939.45 | Mex$2,212.90 | 29 |
Jan ’24 | Mex$4,850.00 | Mex$4,931.87 +1.7% | 9.9% | Mex$5,907.91 | Mex$4,029.90 | Mex$2,459.53 | 28 |
Dec ’23 | Mex$4,458.55 | Mex$4,674.70 +4.8% | 9.7% | Mex$5,520.27 | Mex$3,962.29 | Mex$2,265.00 | 26 |
Nov ’23 | Mex$4,082.00 | Mex$5,743.56 +40.7% | 12.1% | Mex$7,518.47 | Mex$4,527.04 | Mex$1,860.00 | 25 |
Oct ’23 | Mex$4,386.90 | Mex$6,145.01 +40.1% | 8.8% | Mex$7,541.24 | Mex$4,580.76 | Mex$2,440.00 | 25 |
Sep ’23 | Mex$5,072.00 | Mex$6,215.48 +22.5% | 9.7% | Mex$7,653.54 | Mex$4,612.27 | Mex$2,756.26 | 25 |
Aug ’23 | Mex$5,488.67 | Mex$6,164.23 +12.3% | 11.6% | Mex$7,745.96 | Mex$4,667.96 | Mex$2,963.25 | 25 |
Jul ’23 | Mex$5,278.92 | Mex$6,069.81 +15.0% | 12.0% | Mex$7,543.27 | Mex$4,545.81 | Mex$3,375.00 | 26 |
Jun ’23 | Mex$5,040.15 | Mex$6,069.54 +20.4% | 12.0% | Mex$7,547.67 | Mex$4,548.47 | Mex$3,274.18 | 26 |
May ’23 | Mex$5,472.30 | Mex$6,847.67 +25.1% | 10.9% | Mex$8,951.34 | Mex$5,688.89 | Mex$4,411.98 | 27 |
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.